Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.61B 4.21B 536M 463M 435M 396M 745M 51.17B 757M 5.1B 1.99B 25.63B 2.01B 1.97B 85.44B P/E 2026 *
7.94x
P/E 2027 * 7.05x
Enterprise Value 3.61B 4.21B 536M 463M 435M 396M 745M 51.17B 757M 5.1B 1.99B 25.63B 2.01B 1.97B 85.44B EV / Sales 2026 *
0.52x
EV / Sales 2027 * 0.48x
Free-Float
45.7%
Yield 2026 *
5.68%
Yield 2027 * 6.39%
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-27 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-1.35%
1 week-3.10%
Current month-6.82%
1 month-2.09%
3 months-14.36%
6 months-25.28%
Current year-25.62%
1 week 3.26
Extreme 3.255
3.46
1 month 3.26
Extreme 3.255
3.64
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.45
3 years 3.07
Extreme 3.07
7.03
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 37 09/07/2026
Director TitleAgeSince
Director/Board Member 67 10/02/2011
Director/Board Member 69 12/06/2018
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-3.10%-38.23%-52.53% 543M
-0.85%-1.30%-10.66%-8.03% 13.35B
-1.45%-1.41%-32.69%-56.83% 5.05B
-1.44%-3.58%+2.63%+0.58% 4.98B
-0.82%+4.31%+5.02%-30.41% 4.24B
-1.69%-1.90%-15.41%-7.38% 3.65B
-1.96%-9.52%-8.48%-2.27% 3.42B
-0.65%-1.03%-5.95%+15.00% 3.42B
-0.56%+3.11%-14.19%-15.51% 2.5B
+2.56%+13.21%+2.78%-9.09% 1.76B
Average -0.82%-0.94%-11.52%-16.65% 4.29B
Weighted average by Cap. -0.98%-1.82%-10.02%-13.68%

Financials

2026 *2027 *
Net sales 6.98B 8.14B 1.04B 895M 842M 765M 1.44B 98.96B 1.46B 9.86B 3.85B 49.56B 3.89B 3.81B 165B 7.56B 8.82B 1.12B 969M 912M 829M 1.56B 107B 1.59B 10.68B 4.17B 53.68B 4.22B 4.13B 179B
Net income 454M 530M 67.51M 58.25M 54.79M 49.79M 93.8M 6.44B 95.34M 642M 251M 3.23B 253M 248M 10.75B 514M 599M 76.28M 65.81M 61.9M 56.25M 106M 7.28B 108M 725M 283M 3.64B 286M 280M 12.15B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
14/08/26 HK$3.280 -1.35% 857,288
13/08/26 HK$3.325 -3.06% 1,839,000
12/08/26 HK$3.430 +1.93% 1,394,000
11/08/26 HK$3.365 -1.17% 1,228,000
10/08/26 HK$3.405 +1.19% 712,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.819CNY
Average target price
4.601CNY
Spread / Average Target
+63.21%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock